Skip to main content
. 2022 Jul 22;101(29):e29697. doi: 10.1097/MD.0000000000029697

Table 1.

Characteristics of untreated HCV-related cirrhotic and noncirrhotic patients among multiple extrahepatic manifestations after propensity score–matching.

Cirrhosis(N = 1154) Noncirrhosis(N = 6924) P
Age 44.8 ± 20.7 44.5 ± 20.4 .892
Sex Female 613 53.1% 3677 53.1% .971
Male 541 46.9% 3247 46.9%
HCD No 367 31.8% 3095 44.7% <.001
Yes 787 68.2% 3829 55.3%
Hyperlipidemia No 792 68.6% 4251 61.4% <.001
Yes 362 31.4% 2673 38.6%
Diabetes mellitus No 625 54.2% 4736 68.4% <.001
Yes 529 45.8% 2188 31.6%
Chronic kidney disease No 822 71.2% 5512 79.6% <.001
Yes 332 28.8% 1412 20.4%
Hyperthyroidism No 1113 96.4% 6654 96.1% .571
Yes 41 3.6% 270 3.9%
Hypothyroidism No 1122 97.2% 6765 97.7% .690
Yes 32 2.8% 159 2.3%
Thyroiditis No 1123 97.3% 6696 96.7% .302
Yes 31 2.7% 228 3.3%
Non-Hodgkin lymphoma No 1150 99.7% 6882 99.4% .277
Yes 4 0.3% 42 0.6%
Sicca syndrome No 1119 97.0% 6682 96.5% .486
Yes 35 3.0% 242 3.5%
Mixed cryoglobulinemia No 1153 99.9% 6924 100.0% .309
Yes 1 0.1% 0 0.0%
Depression No 1024 88.7% 6162 89.0% .794
Yes 130 11.3% 762 11.0%
Lichen planus No 1141 98.9% 6903 99.7% <.001
Yes 13 1.1% 21 0.3%
Autoimmune hemolytic anemia No 1153 99.9% 6910 99.8% 1.000
Yes 1 0.1% 14 0.2%
Palpable purpura No 1072 92.9% 6786 98.0% <.001
Yes 82 7.1% 138 2.0%
Autoimmune thyroiditis No 1150 99.7% 6903 99.7% .541
Yes 4 0.3% 21 0.3%
Diabetic nephropathy No 1149 99.6% 6882 99.4% .806
Yes 5 0.4% 42 0.6%
Necrolytic acral erythema No 1145 99.2% 6876 99.3% .745
Yes 9 0.8% 48 0.7%
Myocardial infarction No 1111 96.3% 6730 97.2% .085
Yes 43 3.7% 194 2.8%
Congestive heart failure No 692 60.0% 4791 69.2% <.001
Yes 462 40.0% 2133 30.8%
Peripheral arterial disease No 1028 89.1% 6218 89.8% .455
Yes 126 10.9% 706 10.2%
Cerebral vascular disease No 1034 89.6% 6405 92.5% .001
Yes 120 10.4% 519 7.5%
CAD No 741 64.2% 4902 70.8% <.001
Yes 413 35.8% 2022 29.2%

P-values marked in bold indicate statistically significant differences between the groups.